Stephens reiterated their overweight rating on shares of Sensei Biotherapeutics (NASDAQ:SNSE – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $5.00 price objective on the stock. Sensei Biotherapeutics Trading Down 45.5 % NASDAQ:SNSE opened at $0.79 on Friday. The company has a debt-to-equity ratio of […]
Sensei Biotherapeutics (NASDAQ:SNSE) Given Buy Rating at HC Wainwright
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Sensei Biotherapeutics (NASDAQ:SNSE) Stock Rating Reaffirmed by HC Wainwright
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Sensei Biotherapeutics (NASDAQ:SNSE) Receives Overweight Rating from Stephens
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.